CG
PACB icon

Cutler Group’s Pacific Biosciences PACB Stock Holding History

Cutler Group’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,620
Closed -$86.9K – 4138
2023
Q3 		$88K Buy
10,620
+10,500
+8,750% +$120K 0.01% 1193
2023
Q2 		$1K Buy
120
+11
+10% +$134 ﹤0.01% 3362
2023
Q1 		$1K Sell
109
-14,802
-99% -$147K ﹤0.01% 3509
2022
Q4 		$121K Buy
14,911
+2,274
+18% +$19.6K 0.01% 1060
2022
Q3 		$73K Sell
12,637
-289
-2% -$1.66K 0.01% 1619
2022
Q2 		$57K Buy
12,926
+1,392
+12% +$8.46K ﹤0.01% 1853
2022
Q1 		$104K Buy
11,534
+1,520
+15% +$17.5K 0.01% 1677
2021
Q4 		$204K Buy
+10,014
New +$242K 0.01% 1301
2021
Q3 		– Sell
-2,000
Closed -$59.3K – 6192
2021
Q2 		$69K Sell
2,000
-36,504
-95% -$1.06M ﹤0.01% 2210
2021
Q1 		$1.28M Buy
38,504
+38,404
+38,404% +$1.34M 0.06% 344
2020
Q4 		$2K Buy
+100
New +$1.7K ﹤0.01% 4217
2017
Q3 		– Sell
-12,598
Closed -$44K – 6474
2017
Q2 		$44K Buy
12,598
+7,127
+130% +$28.7K ﹤0.01% 2631
2017
Q1 		$28K Sell
5,471
-8,625
-61% -$42.2K ﹤0.01% 2985
2016
Q4 		$53K Sell
14,096
-33,391
-70% -$243K ﹤0.01% 2478
2016
Q3 		$425K Sell
47,487
-4,000
-8% -$33.4K 0.02% 687
2016
Q2 		$362K Buy
51,487
+37,571
+270% +$343K 0.02% 758
2016
Q1 		$118K Buy
13,916
+10,716
+335% +$105K 0.01% 1463
2015
Q4 		$42K Buy
+3,200
New +$28.7K ﹤0.01% 2643

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.39B AUM 10.34% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Cutler Group's PACB Position: Q4 2023 in Review

Cutler Group sold out of Pacific Biosciences (PACB) in Q4 2023, closing a stake of 10,620 shares — an estimated $86.9K sold.

Cutler Group first reported a position in PACB in Q4 2015 and held it in 18 quarters. The position peaked at $1.28M in Q1 2021. 274 funds tracked by Wall St. Rank hold PACB as of Q4 2023.

  • Cutler Group reported no remaining Pacific Biosciences position as of Q4 2023 after selling out during the quarter.
  • Cutler Group sold 10,620 Pacific Biosciences shares in Q4 2023, an estimated $86.9K.
  • Cutler Group first reported a position in Pacific Biosciences in Q4 2015 and held it in 18 quarters.
  • Cutler Group's Pacific Biosciences position peaked at $1.28M in Q1 2021.
  • 274 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.